Oct 08, 2015
| Webcast
Treatment of Disorders: Bone-Kidney Crosstalk
Paul Miller, M.D., FACP; Mary Leonard, M.D.; Tamara Isakova, M.D.; Stuart Sprague, D.O.; Seiji Fukumoto, M.D., Ph.D.
Investigation of Metabolic Bone Diseases, Integrative Physiology of the Skeleton
Chairs:
Paul Miller, M.D., FACP, Colorado Center for Bone Research
Mary Leonard, M.D., Stanford School of Medicine
Speakers:
Phosphate Binding in the Control of FGF23
Tamara Isakova, M.D., Northwestern University
Renal Osteodystrophy/Treatment
Stuart Sprague, D.O., Northshore University Health System
Treatment of FGF23-related Hypophosphatemic Diseases
Seiji Fukumoto, M.D., Ph.D., University of Tokyo Hospital
Supported by an educational grant from Fresenius Medical Care North America, Keryx Biopharmaceuticals, Inc., Lilly, Merck & Co., Inc., Ultragenyx Pharmaceutical Inc.
Length: 60 minutes